RunRagged wrote:
But the current IAAF/WA DSD rules about eligibility in women's events do not apply to anyone with XX DSDs. They apply only to athletes with XY DSDs.
Once again, this is not true. It's what they said in 2019, but it's not what the rules say now. I really don't know why you are having such a hard time understanding something so simple. Here it is again and real slow.
For the rule to apply, the individual must be deemed a Relevant Athlete under 2.2
To be a Relevanat Athlete they must meet 3 criteria:
#1 They must be one of the following DSDs
i. 5α-reductase type 2 deficiency;
ii. partial androgen insensitivity syndrome (PAIS);
iii. 17β-hydroxysteroid dehydrogenase type 3 (17β- HSD3)
deficiency;
iv. ovotesticular DSD; or
v. any other genetic disorder involving disordered gonadal
steroidogenesis; and
#2 As a result, she has circulating testosterone levels in blood of five (5)
nmol/L or above;
#3 She has sufficient androgen sensitivity for those levels of testosterone
to have a material androgenising effect.
ALL 3 criteria can be met in an individual with Ovotesticular DSD with a 46XX Karyotype. They would be barred from competition in events from 400 to a mile. I have already posted about the frequency of this DSD in Africa. I don't know what you don't understand. Contrary to their original stance, the current regulations under 2.2 does ban an XX DSD. We call these facts. It's not even debatable, it's in black and white. What is debatable is if these 2 women have Ovotesticular DSD with a 46XX karyotype. I don't know if they do, I just say it fits the situation.